March 24 is World TB Day. Tuberculosis is a disease that we only hear about occasionally, yet according to the Bill & Gates Foundation, every 20 seconds someone dies from TB. And, it’s getting worse. Resistance to standard treatments is growing and is spreading globally. Its impact on patients and communities is devastating, as powerfully captured by photojournalist James Nachtwey available on XDRTB.org.
But there is hope.
Join us in saluting the efforts of international collaboration to accelerate new regimens of TB medicine and vaccines. The new drug pipeline looks promising and collaborative efforts such as Critical Path to TB Drug Regimens are leading the way for new combination research. TBVI and Aeras are driving forward on their portfolio of new TB vaccines. The Lilly COI’s TBCommons.org site is enabling ease of finding, filtering and sharing insightful views of clinical research. For example, check out this map view of open Phase III TB studies.
This is a tough disease, but one that can be conquered. It will be through commitment and persistence that we see a breakthrough in TB research.
For all those on the front lines of meeting patient needs, we are honored to be part of your efforts.
Got ideas on how we can accelerate TB clinical research more? Drop a comment below.